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A 40 year old Chinese man residing in China was
brought into the emergency room by his family
presenting with grandiose delusions, irritability, and
memory deterioration, which have become
progressively worse in the past 6 months. The patient
was hostile, uncooperative, and was not able to provide
any personal or medical history. Over the past 18
months, the family had noticed dramatic personality
changes that included constricted affect, irritability, and
apathy. They had also noted that the patient
demonstrated ataxia, dysarthria, and progressive
behavioural disturbances such as loss of social graces
and impairment of activities of daily living. The family
recalled that the patient frequently complained of
headaches, vertigo, and non-specific abdominal pain in
the past 6 months. There was no known history of
trauma, malignancy, or vascular disease. He had
developed urinary incontinence 3 weeks ago. The
patient had no known history of substance abuse or
chronic alcohol use. He was not on any medications.
There was no personal or family history of psychiatric
illness. According to the family, the patient was
heterosexual and had been single for at least the past 8
months. It was unknown whether he had a history of a
sexually-transmitted infection or any previous genital
manifestations. The family believes he had been
sexually-active since his early twenties, but it is unclear
as to the number of sexual partners or the use of
condoms. The patient’s mood was highly irritable with
blunted affect. He denied having any suicidal or
homicidal ideation and there was no evidence of
perceptual disturbances. He was admitted for further
evaluation and treatment by neurology and clinical
psychiatry.
PHYSICAL EXAMINATION
The physical examination was remarkable for
neurological findings but was otherwise normal. The
patient was afebrile and vital signs were within normal
limits. Neurological examination revealed a wide-based
gait and ataxia. Pupils in both eyes responded to
accommodation and convergence, but they were not
reactive to light (Argyll Robertson pupils). Cranial
nerve exam was otherwise unremarkable. No
lateralizing signs were present. The patient had
cognitive impairment and grandiose delusions. He
appeared withdrawn and apathetic. The Mini-mental
status examination (MMSE) score was 7/30. MMSE
score and psychiatric symptoms were compatible with
severe cognitive impairment and dementia.
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ABSTRACT: Neurosyphilis is a form of tertiary syphilis infection caused by the spirochete bacterium
Treponema pallidum. Patients suffering from this illness can present with neurological manifestations
such as headaches, seizures, hearing loss, and ataxia. However, the typical presentation of neurosyphilis
is the insidious onset of psychiatric symptoms including personality changes.Agood history and clinical
work-up is essential in the diagnostic process. There has been a recent increase in the incidence of
infectious syphilis in Canada (1). However, in other parts of the world including China, infectious
syphilis rates have remained high due to limited access to primary care and affordable treatments (2
Here, we present a case of neurosyphilis in a 40 year old Chinese male residing in China who presents
with an 18 month history of personality changes as well as neurological and physical manifestations of
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INVESTIGATIONS
Hematological tests were unremarkable. Hepatitis B
and C as well as Human ImmunodeficiencyVirus (HIV)
tests were all negative. Both Treponema Pallidum
Agglutination Assay (TPPA) and Rapid Plasma Reagin
(RPR) yielded positive serum results (RPR serum titre
1:64). Urine toxicology screen was negative. Chest X-
ray and electrocardiogram were normal. Brain MRI
revealed diffuse frontocortical atrophy. A lumbar
puncture revealed a transparent, colourless
cerebrospinal fluid (CSF) with protein of 98mg/dL
(normal: 20-45 mg/dL), white blood cell count of 21/ﾵl
(normal: ≤5ﾵl), and glucose of 3.75mmol/L (normal:
2.5-4.4mmol/l). CSF-RPR and CSF-TPPA were both
positive (CSF-RPR titre 1:8).
TREATMENT AND MANAGEMENT
Based on the investigations, the patient was diagnosed
with neurosyphilis and was treated with Penicillin G 4
million units IV every 4 hours for 14 days, followed by
Penicillin G procaine 2.4 million units IM daily and
probenecid 500mg by mouth four times dailyfor 14
days. His MMSE score before and 8 weeks after
treatment were 7/30 and 21/30 respectively. He
regained bladder control 6 days after the start of
treatment. The patient was discharged after 8 weeks and
is currently being monitored by neurology and
psychiatry for at least the next 2 years. Syphilis
serology will be performed regularly during that time.
DISCUSSION
In Canada, the reported rate of infectious syphilis was
an all-time low of 0.4/100,000 in 1997 with a dramatic
rise to 3.5/100,000 in 2004 (1). The reason for this
increase is unclear, although it appears to be associated
with unsafe sexual practices especially in men who
have sex with men (MSM), illicit intravenous drug use,
and concurrent HIV infection (3). Unfortunately, data
regarding the incidence of neurosyphilis in Canada is
not available. In a systematic review of China’s syphilis
seroprevalence from 2000 to 2005, 660/100,000 of
premarital individuals were reported to have both a
positive screening nontreponemal test (i.e. RPR,
Venereal Disease Research Laboratory (VDRL)) and a
positive treponemal-based confirmatory test (i.e.
Treponema PallidumAgglutinationAssay) (2). In select
high-risk groups in China, incarcerated female sex
workers, drug users, and MSM had syphilis
seroprevalence rates of 12.49%, 6.81%, and 14.56%,
respectively (2). New infections can be vertically
transmitted from mother to baby or more typically,
acquired by sexual contact (4). Syphilis also enhances
the transmission of HIV by 3 to 5 times due to
inflammation in the genital area and the association
with high risk behaviours (5).
Syphilis is caused by the spirochete bacteria
Treponema pallidum. The clinical course can be divided
into several distinct stages: primary, secondary, early
latent, late latent and tertiary stages (6). Primary
syphilis manifests as a painless chancre at the site of
inoculation, typically involving the penis, vagina,
vulva, cervix, anal canal, perianal region, or mouth.
Incubation period ranges from 9 to 90 days from initial
exposure and the infection resolves spontaneously
within 4-5 weeks if untreated (7). Syphilis may recur
systemically as secondary syphilis and is characterized
by constitutional symptoms (fever, malaise, anorexia),
headache, lymphadenopathy, condyloma lata, mucosal
ulceration and a generalized, symmetrical macular-
papular rash involving the trunk, soles and palms (6).
The patient may experience relapsing episodes of
secondary syphilis for several years. After spontaneous
resolution, the infection enters an early latent stage in
which the patient is asymptomatic but has positive
serologic testing and remains highly infectious. Beyond
one year of latency, the asymptomatic infection is
classified as late latent syphilis. Failure to treat may
result in progression to the most serious stage called late
symptomatic syphilis or tertiary syphilis (6).
If untreated in the latent phase, approximately 40% of
patients would then develop tertiary syphilis (4).
Manifestations of tertiary syphilis include
cardiovascular syphilis, gummatous syphilis and
neurosyphilis. Cardiovascular syphilis may occur 15-30
years after primary infection and mainly involve large
vessels, resulting in proximal aortic aneurysm, aortic
regurgitation and angina (7). Gummatous syphilis
presents 3-12 years after primary infection as
inflammatory fibrous nodules that are locally
destructive (7). These lesions can involve any organ of
the body, but usually affect skin or bone. Neurosyphilis
may be divided into early and late forms, of which only
the latter is considered to be tertiary.
Early neurosyphilis commonly affects the CSF,
meninges, and vasculature (8). Manifestations include
asymptomatic or symptomatic meningitis and
meningovascular disease. Less than 2 years after
primary infection, patients may present with
asymptomatic meningitis with CSF abnormalities
including a reactive VDRL, a lymphocytic pleocytosis,
and elevated protein. Lack of treatment at this stage
may result in progression toward more serious forms of
neurosyphilis. Symptomatic meningitis most often
presents in the first year after inoculation. Patients
typically complain of headache, confusion,
nausea/vomiting, stiff neck and decreased visual acuity.
Syphilis may also cause inflammation of the
intracranial vasculature and must be part of the162 McGill Journal of Medicine 2008
differential diagnosis for an ischemic stroke in a young
patient. Meningovascular disease may be visualized on
angiography showing focal narrowing or occlusion (9).
Common forms of late neurosyphilis affect CNS
parenchyma and include general paresis of the insane
(also known as general paresis) and tabes dorsalis (8).
Both forms have poor prognoses without treatment but
are very uncommon in the antibiotic era. General
paresis develops 10-25 years after initial infection and
manifests as a progressive dementia with symptoms of
personality change and poor memory (7). Common
abnormal neurologic findings include facial and limb
hypotonia, dysarthria, and intention tremor. Patients
may exhibit psychiatric symptoms such as depression,
mania, or psychosis and may inadvertently be admitted
to psychiatry. Tabes dorsalis presents with ataxia and
lancinating pains secondary to destruction of the
posterior columns and dorsal roots of the spinal cord.
The pain affects the limbs, trunk and face and described
as sudden, brief and severe. Characteristic Argyll-
Robertson pupils may be present – the pupils respond to
accommodation and convergence but do not react to
light. Other signs and symptoms include paresthesias,
severe episodic nausea/vomiting, impaired vibration
sense and proprioception, and absent lower extremity
reflexes (8).
The diagnosis of neurosyphilis in particular relies
heavily on clinical exam, CSF analysis, and risk factors
including positive HIV status, multiple sexual partners,
illicit IV drug use, MSM, and a previously documented
syphilis infection. If a genital lesion is present, dark-
field microscopy may reveal spirochetes moving with a
spiralling motion (10). Systemic syphilis is detected by
screening serum nontreponemal tests (VDRL, RPR) and
confirmatory treponemal tests (fluorescent treponemal
antibody absorption, FTA-ABS and Treponemal
pallidum particle agglutination assay, TPPA). Late
neurosyphilis may have nonreactive serum non-
treponemal tests. CSF-VDRL is the gold standard for
diagnosing neurosyphilis, although it is not as sensitive
as the less-specific CSF FTA-ABS (11). CSF
demonstrating lymphocytic pleocytosis, high WBC
count, and a high protein concentration is consistent
with neurosyphilis. In a recent, multi-center prospective
study, it was found that patients with serum RPR titres
>= 1:32 were highly predictive of also having
neurosyphilis (defined as a positive CSF-VDRL or CSF
WBC > 20 cells/microliter), regardless of syphilitic
stage, HIV status, or previous non-neurosyphilis
treatment (12). In HIV-positive patients infected with
syphilis, serum RPR titres may be elevated in early HIV
infection compared to HIV-negative patients. In late
stage HIV infection, serologic response to syphilis may
be delayed or absent. These paradoxical findings may
be attributed to B-cell hyperfunctioning and failure,
respectively (13).
The patient in question presented with an insidious
onset of personality change, delusions, and memory
loss. The differential diagnosis of these psychiatric
symptoms in a 40 year old male includes psychiatric
conditions such as schizophrenia, bipolar disorder, and
early-onset Alzheimer’s dementia as well as infectious
causes such as HIV dementia, CNS tuberculosis, herpes
encephalitis, and neurosyphilis, among others. As
neurosyphilis is often called “the great masquerader,” it
is critical to have this diagnosis on the differential of
any patient presenting with insidious onset of
psychiatric symptoms with atypical features. Although
possible, forty years of age is fairly old for new onset
schizophrenia and too young forAlzheimer’s. However,
despite the absence of syphilis risk factors outlined
above, the presence of frequent headaches and the
characteristic Argyll-Robertson pupils in this patient
strongly supported the diagnosis of neurosyphilis even
before formal investigations were carried out.
The standard of treatment for neurosyphilis is
Penicillin G 3-4 million units IV q4h or 24 million units
continuous IV infusion for 10-14 days (14). Penicillin G
procaine 2.4 million units IM qd plus probenecid
500mg po qid for 10-14 days may be given as an
alternative (15). Ceftriaxone 2g IV qd for 10-14 is also
an option (14). Follow-up clinical examination and
lumbar puncture should be scheduled at 3-6 months
after treatment and every 6 months thereafter until the
CSF-VDRL becomes nonreactive and the CSF white
blood cell count normalizes (8). CSF abnormalities
clear typically in 2 years. Prognosis is excellent with
early treatment initiation, but can be poor with
irreversible brain damage.
SUMMARY
Untreated syphilis can progress to a form of tertiary
syphilis called neurosyphilis. This is a serious concern
as the patient begins to demonstrate marked cognitive
and/or behavioural impairment as well as many other
neurological and physical symptoms. Clinical suspicion
of neurosyphilis can be made based on a detailed
medical history and physical exam including a history
of high-risk behaviours, previous documented syphilis
infection, insidious onset of psychiatric symptoms,
headaches and characteristic neurological findings such
as Argyll-Robertson pupils. The diagnosis can be
confirmed with serum non-treponemal tests such as
VDRL and RPR, serum treponemal tests such as FTA-
ABS and TPPA, and neurosyphilis-specific tests, such
as CSF-RPR and CSF-VDRL. The outcome of patient
with neurosyphilis is highly dependent on the amount of
brain damage and the extent of disability before theA Case of Neurosyphilis 163 Vol. 11 No. 2
initiation of treatment.
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